Targeting calcium signaling in cancer therapy
Tóm tắt
Từ khóa
Tài liệu tham khảo
Berridge, 2000, The versatility and universality of calcium signalling, Nat Rev Mol Cell Biol, 1, 11, 10.1038/35036035
Csordas, 2010, Imaging interorganelle contacts and local calcium dynamics at the ER-mitochondrial interface, Mol Cell, 39, 121, 10.1016/j.molcel.2010.06.029
McConkey, 1997, The role of calcium in the regulation of apoptosis, Biochem Biophys Res Commun, 239, 357, 10.1006/bbrc.1997.7409
Baudouin-Legros, 2003, Effect of ouabain on CFTR gene expression in human Calu-3 cells, Am J Physiol Cell Physiol, 284, C620, 10.1152/ajpcell.00457.2002
Zhu, 2014, Elevated Orai1 expression mediates tumor-promoting intracellular Ca2+ oscillations in human esophageal squamous cell carcinoma, Oncotarget, 5, 3455, 10.18632/oncotarget.1903
Parekh, 2011, Decoding cytosolic Ca2+ oscillations, Trends Biochem Sci, 36, 78, 10.1016/j.tibs.2010.07.013
Smedler, 2013, Frequency decoding of calcium oscillations, Biochim Biophys Acta
Cullen, 2003, Calcium signalling: the ups and downs of protein kinase C, Curr Biol, 13, R699, 10.1016/j.cub.2003.08.041
Hu, 1999, [Ca2+]i Oscillation frequency regulates agonist-stimulated NF-κB transcriptional activity, J Biol Chem, 274, 33995, 10.1074/jbc.274.48.33995
Dolmetsch, 1998, Calcium oscillations increase the efficiency and specificity of gene expression, Nature, 392, 933, 10.1038/31960
Kondratskyi, 2013, Calcium-permeable ion channels in control of autophagy and cancer, Front Physiol, 4, 272, 10.3389/fphys.2013.00272
Gu, 1995, Thapsigargin increases apoptotic cell death in human hepatoma BEL-7404 cells, Cell Res, 5, 59, 10.1038/cr.1995.6
Vandewalle, 1995, Vitamin-D3 derivatives and breast-tumor cell growth: effect on intracellular calcium and apoptosis, Int J Cancer, 61, 806, 10.1002/ijc.2910610611
Liu, 2001, Squamous cell tumors in mice heterozygous for a null allele of Atp2a2, encoding the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 Ca2+ pump, J Biol Chem, 276, 26737, 10.1074/jbc.C100275200
Roderick, 2008, Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival, Nat Rev Cancer, 8, 361, 10.1038/nrc2374
Gkika, 2011, TRP channels in prostate cancer: the good, the bad and the ugly?, Asian J Androl, 13, 673, 10.1038/aja.2011.18
Karacosta, 2012, A regulatory feedback loop between Ca2+/calmodulin--dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression, J Biol Chem, 287, 24832, 10.1074/jbc.M112.370783
Monteith, 2012, Calcium channels and pumps in cancer: changes and consequences, J Biol Chem, 287, 31666, 10.1074/jbc.R112.343061
Vervloessem, 2015, The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca2+-release channel, Biochim Biophys Acta, 1853, 1992, 10.1016/j.bbamcr.2014.12.006
Rizzuto, 2009, Ca2+ transfer from the ER to mitochondria: when, how and why, Biochim Biophys Acta, 1787, 1342, 10.1016/j.bbabio.2009.03.015
Kang, 2010, Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival, Cancer Res, 70, 1173, 10.1158/0008-5472.CAN-09-2886
Sakakura, 2003, Possible involvement of inositol 1,4,5-trisphosphate receptor type 3 (IP3R3) in the peritoneal dissemination of gastric cancers, Anticancer Res, 23, 3691
Shibao, 2010, The type III inositol 1,4,5-trisphosphate receptor is associated with aggressiveness of colorectal carcinoma, Cell calcium, 48, 315, 10.1016/j.ceca.2010.09.005
Hedberg, 2016, Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma, J Clin Invest, 126, 169, 10.1172/JCI82066
Akl, 2013, IP3R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP3R-derived peptide targeting the BH4 domain of Bcl-2, Cell Death Dis, 4, e632, 10.1038/cddis.2013.140
Ouyang, 2014, Loss of IP3R-dependent Ca2+ signalling in thymocytes leads to aberrant development and acute lymphoblastic leukemia, Nat Commun, 5, 4814, 10.1038/ncomms5814
Krebs, 2015, The plethora of PMCA isoforms: alternative splicing and differential expression, Biochim Biophys Acta, 1853, 2018, 10.1016/j.bbamcr.2014.12.020
Dang, 2015, Calcium-ATPases: gene disorders and dysregulation in cancer, Biochim Biophys Acta
Fan, 2014, Novel role of Sarco/endoplasmic reticulum calcium ATPase 2 in development of colorectal cancer and its regulation by F36, a curcumin analog, Biomed Pharmacother, 68, 1141, 10.1016/j.biopha.2014.10.014
Brouland, 2005, The loss of sarco/endoplasmic reticulum calcium transport ATPase 3 expression is an early event during the multistep process of colon carcinogenesis, Am J Pathol, 167, 233, 10.1016/S0002-9440(10)62968-9
Dellis, 2009, Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein–Barr virus latent membrane protein-1, Mol Cancer, 8, 59, 10.1186/1476-4598-8-59
Grice, 2010, Golgi calcium pump secretory pathway calcium ATPase 1 (SPCA1) is a key regulator of insulin-like growth factor receptor (IGF1R) processing in the basal-like breast cancer cell line MDA-MB-231, J Biol Chem, 285, 37458, 10.1074/jbc.M110.163329
Feng, 2010, Store-independent activation of Orai1 by SPCA2 in mammary tumors, Cell, 143, 84, 10.1016/j.cell.2010.08.040
Lee, 2005, Plasma membrane calcium-ATPase 2 and 4 in human breast cancer cell lines, Biochem Biophys Res Commun, 337, 779, 10.1016/j.bbrc.2005.09.119
Aung, 2007, Plasma membrane Ca2+-ATPase expression during colon cancer cell line differentiation, Biochem Biophys Res Commun, 355, 932, 10.1016/j.bbrc.2007.02.050
Saito, 2006, Plasma membrane Ca2+ ATPase isoform 1 down-regulated in human oral cancer, Oncol Rep, 15, 49
Catterall, 2000, Structure and regulation of voltage-gated Ca2+ channels, Annu Rev Cell Dev Biol, 16, 521, 10.1146/annurev.cellbio.16.1.521
Wang, 2015, Meta-analysis of public microarray datasets reveals voltage-gated calcium gene signatures in clinical cancer patients, PLoS One, 10, e0125766, 10.1371/journal.pone.0125766
Kale, 2015, Targeting ion channels for cancer therapy by repurposing the approved drugs, Biochim Et Biophys Acta (BBA)-Biomembr, 1848, 2747, 10.1016/j.bbamem.2015.03.034
Dziegielewska, 2014, T-type calcium channels blockers as new tools in cancer therapies, Pflugers Arch, 466, 801, 10.1007/s00424-014-1444-z
Ohkubo, 2012, T-type voltage-activated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF-7 human breast cancer cells, Int J Oncol, 41, 267
Gackiere, 2008, CaV3.2 T-type calcium channels are involved in calcium-dependent secretion of neuroendocrine prostate cancer cells, J Biol Chem, 283, 10162, 10.1074/jbc.M707159200
Latour, 2004, Expression of T-type calcium channel splice variants in human glioma, Glia, 48, 112, 10.1002/glia.20063
Wu, 2010, International union of basic and clinical pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family, Pharmacol Rev, 62, 381, 10.1124/pr.110.002725
Nilius, 2007, TRP channels in disease, Biochim Biophys Acta, 1772, 805, 10.1016/j.bbadis.2007.02.002
El Hiani, 2009, Activation of the calcium-sensing receptor by high calcium induced breast cancer cell proliferation and TRPC1 cation channel over-expression potentially through EGFR pathways, Arch Biochem Biophys, 486, 58, 10.1016/j.abb.2009.03.010
Yang, 2009, Transient receptor potential channel C3 contributes to the progression of human ovarian cancer, Oncogene, 28, 1320, 10.1038/onc.2008.475
Aydar, 2009, Abnormal expression, localization and interaction of canonical transient receptor potential ion channels in human breast cancer cell lines and tissues: a potential target for breast cancer diagnosis and therapy, Cancer Cell Int, 9, 23, 10.1186/1475-2867-9-23
Prevarskaya, 2007, TRP channels in cancer, Biochim Biophys Acta, 1772, 937, 10.1016/j.bbadis.2007.05.006
Ouadid-Ahidouch, 2013, TRP channels: diagnostic markers and therapeutic targets for breast cancer?, Trends Mol Med, 19, 117, 10.1016/j.molmed.2012.11.004
Ding, 2010, Targeting TRPC6 channels in oesophageal carcinoma growth, Expert Opin Ther Targets, 14, 513, 10.1517/14728221003733602
Monet, 2010, Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance, Cancer Res, 70, 1225, 10.1158/0008-5472.CAN-09-2205
Zhang, 2006, TRPM8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function?, Endocr-Relat Cancer, 13, 27, 10.1677/erc.1.01093
Zhang, 2013, High expression of transient potential receptor C6 correlated with poor prognosis in patients with esophageal squamous cell carcinoma, Med Oncol, 30, 607, 10.1007/s12032-013-0607-7
Tsavaler, 2001, Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins, Cancer Res, 61, 3760
Dhennin-Duthille, 2011, High expression of transient receptor potential channels in human breast cancer epithelial cells and tissues: correlation with pathological parameters, Cell Physiol Biochem, 28, 813, 10.1159/000335795
Guilbert, 2009, Evidence that TRPM7 is required for breast cancer cell proliferation, Am J Physiol Cell Physiol, 297, C493, 10.1152/ajpcell.00624.2008
Chodon, 2010, Estrogen regulation of TRPM8 expression in breast cancer cells, BMC Cancer, 10, 212, 10.1186/1471-2407-10-212
Clark, 2008, Interplay between TRP channels and the cytoskeleton in health and disease, Eur J Cell Biol, 87, 631, 10.1016/j.ejcb.2008.01.009
Bergmeier W, Weidinger C, Zee I, Feske S. Emerging roles of store-operated Ca2+ entry through STIM and ORAI proteins in immunity, hemostasis and cancer. Channels (Austin) 2013;7:379-91
Yang, 2009, Orai1 and STIM1 are critical for breast tumor cell migration and metastasis, Cancer Cell, 15, 124, 10.1016/j.ccr.2008.12.019
Motiani, 2013, STIM1 and Orai1 mediate CRAC channel activity and are essential for human glioblastoma invasion, Pflugers Arch, 465, 1249, 10.1007/s00424-013-1254-8
Kondratska, 2014, Orai1 and STIM1 mediate SOCE and contribute to apoptotic resistance of pancreatic adenocarcinoma, Biochim Biophys Acta, 1843, 2263, 10.1016/j.bbamcr.2014.02.012
Flourakis, 2010, Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells, Cell Death Dis, 1, e75, 10.1038/cddis.2010.52
Dubois, 2014, Remodeling of channel-forming ORAI proteins determines an oncogenic switch in prostate cancer, Cancer Cell, 26, 19, 10.1016/j.ccr.2014.04.025
Yang, 2013, Blockade of store-operated Ca2+ entry inhibits hepatocarcinoma cell migration and invasion by regulating focal adhesion turnover, Cancer Lett, 330, 163, 10.1016/j.canlet.2012.11.040
Kim, 2014, Orai1 and STIM1 are critical for cell migration and proliferation of clear cell renal cell carcinoma, Biochem Biophys Res Commun, 448, 76, 10.1016/j.bbrc.2014.04.064
Weidinger, 2013, STIM1 and STIM2-mediated Ca2+ influx regulates antitumour immunity by CD8+ T cells, EMBO Mol Med, 5, 1311, 10.1002/emmm.201302989
Oh-Hora, 2008, Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance, Nat Immunol, 9, 432, 10.1038/ni1574
Aytes, 2012, Stromal interaction molecule 2 (STIM2) is frequently overexpressed in colorectal tumors and confers a tumor cell growth suppressor phenotype, Mol Carcinog, 51, 746, 10.1002/mc.20843
Stanisz, 2014, Inverse regulation of melanoma growth and migration by Orai1/STIM2-dependent calcium entry, Pigment Cell Melanoma Res, 27, 442, 10.1111/pcmr.12222
Faouzi, 2011, Down-regulation of Orai3 arrests cell-cycle progression and induces apoptosis in breast cancer cells but not in normal breast epithelial cells, J Cell Physiol, 226, 542, 10.1002/jcp.22363
Ay, 2013, Orai3 constitutes a native store-operated calcium entry that regulates non small cell lung adenocarcinoma cell proliferation, PLoS One, 8, e72889, 10.1371/journal.pone.0072889
Motiani, 2013, Orai3 is an estrogen receptor alpha-regulated Ca2+ channel that promotes tumorigenesis, Faseb J, 27, 63, 10.1096/fj.12-213801
Motiani, 2010, A novel native store-operated calcium channel encoded by Orai3: selective requirement of Orai3 versus Orai1 in estrogen receptor-positive versus estrogen receptor-negative breast cancer cells, J Biol Chem, 285, 19173, 10.1074/jbc.M110.102582
Pan, 2015, Open Sesame: treasure in store-operated calcium entry pathway for cancer therapy, Sci China Life Sci, 58, 48, 10.1007/s11427-014-4774-3
Giannuzzo, 2015, The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells, Mol Cancer, 14, 1, 10.1186/s12943-015-0472-4
Jin, 2014, P2Y2 receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells, Breast Cancer Res, 16, R77, 10.1186/bcr3694
Xie, 2014, The P2Y2 nucleotide receptor mediates the proliferation and migration of human hepatocellular carcinoma cells induced by ATP, J Biol Chem, 289, 19137, 10.1074/jbc.M113.540047
Nylund, 2007, P2Y2- and P2Y4 purinergic receptors are over-expressed in human colon cancer, Auton Autacoid Pharmacol, 27, 79, 10.1111/j.1474-8673.2007.00389.x
Maynard, 2015, P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients, Oncotarget, 6, 41162, 10.18632/oncotarget.6240
Csordas, 2013, MICU1 controls both the threshold and cooperative activation of the mitochondrial Ca2+ uniporter, Cell Metab, 17, 976, 10.1016/j.cmet.2013.04.020
Brookes, 2004, Calcium, ATP, and ROS: a mitochondrial love-hate triangle, Am J Physiol Cell Physiol, 287, C817, 10.1152/ajpcell.00139.2004
Curry, 2013, Mitochondrial calcium uniporter silencing potentiates caspase-independent cell death in MDA-MB-231 breast cancer cells, Biochem Biophys Res Commun, 434, 695, 10.1016/j.bbrc.2013.04.015
Marchi, 2013, Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25, Curr Biol, 23, 58, 10.1016/j.cub.2012.11.026
Mallilankaraman, 2012, MICU1 is an essential gatekeeper for MCU-mediated mitochondrial Ca2+ uptake that regulates cell survival, Cell, 151, 630, 10.1016/j.cell.2012.10.011
Ding, 2010, Essential role of TRPC6 channels in G2/M phase transition and development of human glioma, J Natl Cancer Inst, 102, 1052, 10.1093/jnci/djq217
Duncan, 1998, Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis, Cancer Res, 58, 1515
Yee, 2012, TRPM7 and TRPM8 ion channels in pancreatic adenocarcinoma: potential roles as cancer biomarkers and targets, Sci (Cairo), 415158
Liu, 2011, TRPM8 in health and disease: cold sensing and beyond, Adv Exp Med Biol, 704, 185, 10.1007/978-94-007-0265-3_10
Kalogris, 2010, Expression of transient receptor potential vanilloid-1 (TRPV1) in urothelial cancers of human bladder: relation to clinicopathological and molecular parameters, Histopathology, 57, 744, 10.1111/j.1365-2559.2010.03683.x
Sanchez, 2005, Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue, Eur J Pharmacol, 515, 20, 10.1016/j.ejphar.2005.04.010
Perálvarez-Marín, 2013, What do we know about the transient receptor potential vanilloid 2 (TRPV2) ion channel?, FEBS J, 280, 5471, 10.1111/febs.12302
Fusi, 2014, Transient receptor potential vanilloid 4 (TRPV4) is downregulated in keratinocytes in human non-melanoma skin cancer, J Invest Dermatol, 134, 2408, 10.1038/jid.2014.145
Adapala, 2016, Activation of mechanosensitive ion channel TRPV4 normalizes tumor vasculature and improves cancer therapy, Oncogene, 35, 314, 10.1038/onc.2015.83
Fiorio Pla, 2012, TRPV4 mediates tumor-derived endothelial cell migration via arachidonic acid-activated actin remodeling, Oncogene, 31, 200, 10.1038/onc.2011.231
Raphael, 2014, TRPV6 calcium channel translocates to the plasma membrane via Orai1-mediated mechanism and controls cancer cell survival, Proc Natl Acad Sci U S A, 10.1073/pnas.1413409111
Lau, 2014, Capsaicin induces apoptosis in human small cell lung cancer via the TRPV6 receptor and the calpain pathway, Apoptosis, 19, 1190, 10.1007/s10495-014-1007-y
Peters, 2012, Calcium channel TRPV6 as a potential therapeutic target in estrogen receptor-negative breast cancer, Mol Cancer Ther, 11, 2158, 10.1158/1535-7163.MCT-11-0965
Vy, 2012, The role of the TRPV6 channel in cancer, J Physiol, 590, 1369, 10.1113/jphysiol.2011.225862
Sun, 2014, STIM1- and Orai1-mediated Ca2+ oscillation orchestrates invadopodium formation and melanoma invasion, J Cell Biol, 207, 535, 10.1083/jcb.201407082
Moccia, 2014, Orai1 and transient receptor potential channels as novel molecular targets to impair tumor neovascularization in renal cell carcinoma and other malignancies, Anti-Cancer Agents Med Chem, 14, 296, 10.2174/18715206113139990315
Zhan, 2015, Over-expression of Orai1 mediates cell proliferation and associates with poor prognosis in human non-small cell lung carcinoma, Int J Clin Exp Pathol, 8, 5080
Chen, 2011, Calcium store sensor stromal-interaction molecule 1-dependent signaling plays an important role in cervical cancer growth, migration, and angiogenesis, Proc Natl Acad Sci U S A, 108, 15225, 10.1073/pnas.1103315108
Wang, 2015, STIM1 overexpression promotes colorectal cancer progression, cell motility and COX-2 expression, Oncogene, 34, 4358, 10.1038/onc.2014.366
McAndrew, 2011, ORAI1-mediated calcium influx in lactation and in breast cancer, Mol Cancer Ther, 10, 448, 10.1158/1535-7163.MCT-10-0923
Sobradillo, 2014, A reciprocal shift in transient receptor potential channel 1 (TRPC1) and stromal interaction molecule 2 (STIM2) contributes to Ca2+ remodeling and cancer hallmarks in colorectal carcinoma cells, J Biol Chem, 289, 28765, 10.1074/jbc.M114.581678
Yao, 2011, Synthesis and SERCA activities of structurally simplified cyclopiazonic acid analogues, Bioorg Med Chem, 19, 4669, 10.1016/j.bmc.2011.06.001
Denmeade, 2012, Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy, Sci Transl Med, 4, 140ra86, 10.1126/scitranslmed.3003886
Wong, 2013, Saikosaponin-d, a novel SERCA inhibitor, induces autophagic cell death in apoptosis-defective cells, Cell Death Dis, 4, e720, 10.1038/cddis.2013.217
Law, 2010, Alisol B, a novel inhibitor of the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase pump, induces autophagy, endoplasmic reticulum stress, and apoptosis, Mol Cancer Ther, 9, 718, 10.1158/1535-7163.MCT-09-0700
Bergamo, 2009, Inhibitory effects of the ruthenium complex KP1019 in models of mammary cancer cell migration and invasion, Metal-Based Drugs, 681270
Yang, 2015, Small molecule RL71 targets SERCA2 at a novel site in the treatment of human colorectal cancer, Oncotarget, 6, 37613, 10.18632/oncotarget.6068
Muscella, 2011, The platinum (II) complex [Pt(O,O׳-acac)(γ-acac)(DMS)] alters the intracellular calcium homeostasis in MCF-7 breast cancer cells, Biochem Pharmacol, 81, 91, 10.1016/j.bcp.2010.09.012
Rim, 2012, T-type Ca2+ channel blocker, KYS05047 induces G1 phase cell cycle arrest by decreasing intracellular Ca2+ levels in human lung adenocarcinoma A549 cells, Bioorg Med Chem Lett, 22, 7123, 10.1016/j.bmcl.2012.09.076
Kim, 2015, NNC 55-0396, a T-type Ca2+ channel inhibitor, inhibits angiogenesis via suppression of hypoxia-inducible factor-1α signal transduction, J Mol Med (Berl), 93, 499, 10.1007/s00109-014-1235-1
Yoshida, 2007, G1 cell cycle arrest by amlodipine, a dihydropyridine Ca2+ channel blocker, in human epidermoid carcinoma A431 cells, Biochem Pharmacol, 73, 943, 10.1016/j.bcp.2006.12.011
Garrido-Laguna, 2008, Activity of the T-type calcium channel antagonist Mibefradil in pancreatic cancer xenografts, Clin Cancer Res, 14
Diaz-Lezama, 2010, Ghrelin inhibits proliferation and increases T-type Ca2+ channel expression in PC-3 human prostate carcinoma cells, Biochem Biophys Res Commun, 403, 24, 10.1016/j.bbrc.2010.10.100
Shigetomi, 2012, TRPA1 channels regulate astrocyte resting calcium and inhibitory synapse efficacy through GAT-3, Nat Neurosci, 15, 70, 10.1038/nn.3000
Dasari, 2015, Wittig derivatization of sesquiterpenoid polygodial leads to cytostatic agents with activity against drug resistant cancer cells and capable of pyrrolylation of primary amines, Eur J Med Chem, 103, 226, 10.1016/j.ejmech.2015.08.047
Hwang, 2013, 20-O-β-d-glucopyranosyl-20(S)-protopanaxadiol, a metabolite of ginseng, inhibits colon cancer growth by targeting TRPC channel-mediated calcium influx, J Nutr Biochem, 24, 1096, 10.1016/j.jnutbio.2012.08.008
Zhu, 2015, Identification and optimization of 2-aminobenzimidazole derivatives as novel inhibitors of TRPC4 and TRPC5 channels, Br J Pharmacol, 172, 3495, 10.1111/bph.13140
He, 2005, A functional link between store-operated and TRPC channels revealed by the 3,5-bis(trifluoromethyl)pyrazole derivative, BTP2, J Biol Chem, 280, 10997, 10.1074/jbc.M411797200
Vigont, 2012, Store-operated calcium entry into SK-N-SH human neuroblastoma cells modeling huntington׳s disease, Biochem (Mosc) Suppl Ser A: Membr Cell Biol, 6, 206, 10.1134/S199074781201014X
Akbulut, 2015, (−)-Englerin A is a potent and selective activator of TRPC4 and TRPC5 calcium channels, Angew Chem Int Ed Engl, 54, 3787, 10.1002/anie.201411511
Carson, 2015, Englerin A agonizes the TRPC4/C5 cation channels to inhibit tumor cell line proliferation, PLoS One, 10, e0127498, 10.1371/journal.pone.0127498
Miller, 2011, Identification of ML204, a novel potent antagonist that selectively modulates native TRPC4/C5 ion channels, J Biol Chem, 286, 33436, 10.1074/jbc.M111.274167
Seo, 2014, Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy, Proc Natl Acad Sci U S A, 111, 1551, 10.1073/pnas.1308963111
Madan, 2013, p53 increases intra-cellular calcium release by transcriptional regulation of calcium channel TRPC6 in GaQ3-treated cancer cells, PLoS One, 8, e71016, 10.1371/journal.pone.0071016
Gonzales, 2014, Vanilloids induce oral cancer apoptosis independent of TRPV1, Oral Oncol, 50, 437, 10.1016/j.oraloncology.2013.12.023
Yang, 2015, Structural mechanism underlying capsaicin binding and activation of the TRPV1 ion channel, Nat Chem Biol, 11, 518, 10.1038/nchembio.1835
Costa, 2004, Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation, Br J Pharmacol, 143, 247, 10.1038/sj.bjp.0705920
Liu, 2016, Capsaicin mediates caspases activation and induces apoptosis through P38 and JNK MAPK pathways in human renal carcinoma, BMC Cancer, 16, 790, 10.1186/s12885-016-2831-y
de Jong, 2014, Ion channel TRPV1-dependent activation of PTP1B suppresses EGFR-associated intestinal tumorigenesis, J Clin Invest, 124, 3793, 10.1172/JCI72340
Juvin, 2007, Pharmacological characterization and molecular determinants of the activation of transient receptor potential V2 channel orthologs by 2-aminoethoxydiphenyl borate, Mol Pharmacol, 72, 1258, 10.1124/mol.107.037044
Velasco, 2016, The use of cannabinoids as anticancer agents, Prog Neuro-Psychopharmacol Biol Psychiatry, 64, 259, 10.1016/j.pnpbp.2015.05.010
Nie, 1997, Inhibition of proliferation of MCF-7 breast cancer cells by a blocker of Ca2+-permeable channel, Cell Calcium, 22, 75, 10.1016/S0143-4160(97)90107-X
Thorneloe, 2011, Discovery of orally active transient receptor potential vanilloid 4 (TRPV4) blockers for the treatment of pulmonary edema in heart failure, Circulation, 124, A13510
Wei, 2015, Identification of orally-bioavailable antagonists of the TRPV4 ion-channel, Bioorg Med Chem Lett, 25, 4011, 10.1016/j.bmcl.2015.06.098
Takezawa, 2006, A pyrazole derivative potently inhibits lymphocyte Ca2+ influx and cytokine production by facilitating transient receptor potential melastatin 4 channel activity, Mol Pharmacol, 69, 1413, 10.1124/mol.105.021154
De Petrocellis, 2011, Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes, Br J Pharmacol, 163, 1479, 10.1111/j.1476-5381.2010.01166.x
Almeida, 2012, Pharmacological blockade of the cold receptor TRPM8 attenuates autonomic and behavioral cold defenses and decreases deep body temperature, J Neurosci, 32, 2086, 10.1523/JNEUROSCI.5606-11.2012
Yee NS. Roles of TRPM8 ion channels in cancer: proliferation, survival, and invasion Cancers (Basel) 2015;7:2134-2146.
Tolcher, 2010, 376 Preliminary results from a Phase 1 study of D-3263 HCl, a TRPM8 calcium channel agonist, in patients with advanced cancer, Eur J Cancer Suppl, 8, 119, 10.1016/S1359-6349(10)72083-8
Wang, 2015, Up-regulation of lysosomal TRPML1 channels is essential for lysosomal adaptation to nutrient starvation, Proc Natl Acad Sci U S A, 112, E1373, 10.1073/pnas.1419669112
Chen, 2014, A small molecule restores function to TRPML1 mutant isoforms responsible for mucolipidosis type IV, Nat Commun, 5, 4681, 10.1038/ncomms5681
Landowski, 2011, Chemical inhibitors of the calcium entry channel TRPV6, Pharm Res, 28, 322, 10.1007/s11095-010-0249-9
Bowen, 2013, In vivo detection of human TRPV6-rich tumors with anti-cancer peptides derived from soricidin, PLoS One, 8, e58866, 10.1371/journal.pone.0058866
Haverstick, 2000, Inhibition of human prostate cancer proliferation in vitro and in a mouse model by a compound synthesized to block Ca2+ entry, Cancer Res, 60, 1002
Perabo, 2004, Carboxyamido-triazole (CAI), a signal transduction inhibitor induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2, Anticancer Res, 24, 2869
Harper, 2003, Dihydropyridines as inhibitors of capacitative calcium entry in leukemic HL-60 cells, Biochem Pharmacol, 65, 329, 10.1016/S0006-2952(02)01488-0
Yoshino, 2007, YM-58483, a selective CRAC channel inhibitor, prevents antigen-induced airway eosinophilia and late phase asthmatic responses via Th2 cytokine inhibition in animal models, Eur J Pharmacol, 560, 225, 10.1016/j.ejphar.2007.01.012
Dutcher, 2005, Phase II study of carboxyamidotriazole in patients with advanced renal cell carcinoma refractory to immunotherapy: e4896, an Eastern Cooperative Oncology Group Study, Cancer, 104, 2392, 10.1002/cncr.21473
Moody, 2003, CAI inhibits the growth of small cell lung cancer cells, Lung Cancer, 39, 279, 10.1016/S0169-5002(02)00525-1
Smyth, 2008, Ca2+-store-dependent and -independent reversal of Stim1 localization and function, J Cell Sci, 121, 762, 10.1242/jcs.023903
Kondratskyi, 2014, Identification of ML-9 as a lysosomotropic agent targeting autophagy and cell death, Cell Death Dis, 5, e1193, 10.1038/cddis.2014.156
McNally, 2012, Gated regulation of CRAC channel ion selectivity by STIM1, Nature, 482, 241, 10.1038/nature10752
Yeromin, 2006, Molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai, Nature, 443, 226, 10.1038/nature05108
Sampath, 2016, Glu106 targeted inhibitors of ORAI1 as potential Ca release-activated Ca (CRAC) channel blockers - molecular modeling and docking studies, J Recept Signal Transduct Res, 1
Derler, 2013, The action of selective CRAC channel blockers is affected by the Orai pore geometry, Cell Calcium, 53, 139, 10.1016/j.ceca.2012.11.005
Sadaghiani, 2014, Identification of Orai1 channel inhibitors by using minimal functional domains to screen small molecule microarrays, Chem Biol, 21, 1278, 10.1016/j.chembiol.2014.08.016
Prakriya, 2001, Potentiation and inhibition of Ca2+ release-activated Ca2+ channels by 2-aminoethyldiphenyl borate (2-APB) occurs independently of IP3 receptors, J Physiol, 536, 3, 10.1111/j.1469-7793.2001.t01-1-00003.x
Goto, 2010, Two novel 2-aminoethyl diphenylborinate (2-APB) analogues differentially activate and inhibit store-operated Ca2+ entry via STIM proteins, Cell Calcium, 47, 1, 10.1016/j.ceca.2009.10.004
Chen, 2013, Characterization of a novel CRAC inhibitor that potently blocks human T cell activation and effector functions, Mol Immunol, 54, 355, 10.1016/j.molimm.2012.12.011
Small, 2000, Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone, J Clin Oncol, 18, 1440, 10.1200/JCO.2000.18.7.1440
Adinolfi, 2012, Expression of P2X7 receptor increases in vivo tumor growth, Cancer Res, 72, 2957, 10.1158/0008-5472.CAN-11-1947
Adinolfi, 2015, Emerging roles of P2X receptors in cancer, Curr Med Chem, 22, 878, 10.2174/0929867321666141012172913
Mariot, 2000, Evidence of functional ryanodine receptor involved in apoptosis of prostate cancer (LNCaP) cells, Prostate, 43, 205, 10.1002/(SICI)1097-0045(20000515)43:3<205::AID-PROS6>3.0.CO;2-M
Abdul, 2008, Ryanodine receptor expression correlates with tumor grade in breast cancer, Pathol Oncol Res, 14, 157, 10.1007/s12253-008-9045-9
Garcia-Prieto, 2013, Effective killing of leukemia cells by the natural product OSW-1 through disruption of cellular calcium homeostasis, J Biol Chem, 288, 3240, 10.1074/jbc.M112.384776
Kim, 2008, N,N-dimethyl-D-erythro-sphingosine increases intracellular Ca2+ concentration via Na+–Ca2+-exchanger in HCT116 human colonolocancer cells, Arch Pharm Res, 31, 54, 10.1007/s12272-008-1120-y
Lee, 1996, Bepridil enhances in vitro antitumor activity of antiestrogens in human brain tumor cells, Cancer Lett, 110, 243, 10.1016/S0304-3835(96)04518-1
Cox, 1993, Selectivity of inhibition of Na+–Ca2+ exchange of heart mitochondria by benzothiazepine CGP-37157, J Cardiovasc Pharmacol, 21, 595, 10.1097/00005344-199304000-00013
Jost, 2013, ORM-10103, a novel specific inhibitor of the Na+/Ca2+ exchanger, decreases early and delayed afterdepolarizations in the canine heart, Br J Pharmacol, 170, 768, 10.1111/bph.12228
Brustovetsky, 2011, KB-R7943, an inhibitor of the reverse Na+/Ca2+ exchanger, blocks N-methyl-D-aspartate receptor and inhibits mitochondrial complex I, Br J Pharmacol, 162, 255, 10.1111/j.1476-5381.2010.01054.x
Song, 2014, The TRPC channel blocker SKF 96365 inhibits glioblastoma cell growth by enhancing reverse mode of the Na+/Ca2+ exchanger and increasing intracellular Ca2+, Br J Pharmacol, 171, 3432, 10.1111/bph.12691
Jaimovich, 2005, Xestospongin B, a competitive inhibitor of IP3-mediated Ca2+ signalling in cultured rat myotubes, isolated myonuclei, and neuroblastoma (NG108-15) cells, FEBS Lett, 579, 2051, 10.1016/j.febslet.2005.02.053
Miyamoto, 2000, a selective and membrane-permeable inhibitor of IP3 receptor, attenuates the positive inotropic effect of α-adrenergic stimulation in guinea-pig papillary muscle, Br J Pharmacol, 130, 650, 10.1038/sj.bjp.0703358
Cárdenas, 2016, Selective vulnerability of cancer cells by inhibition of Ca2+ transfer from endoplasmic reticulum to mitochondria, Cell Rep, 14, 2313, 10.1016/j.celrep.2016.02.030
Maruyama, 1997, 2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of Ins(1,4,5)P3-induced Ca2+ release, J Biochem, 122, 498, 10.1093/oxfordjournals.jbchem.a021780
Saleem, 2014, Interactions of antagonists with subtypes of inositol 1,4,5-trisphosphate (IP3) receptor, Br J Pharmacol, 171, 3298, 10.1111/bph.12685
Kang, 2010, Inhibition of the Ca2+ release channel, IP3R subtype 3 by caffeine slows glioblastoma invasion and migration and extends survival, Cancer Res, 70, 1173, 10.1158/0008-5472.CAN-09-2886
Pan, 2000, Depletion of intracellular Ca2+ by caffeine and ryanodine induces apoptosis of chinese hamster ovary cells transfected with ryanodine receptor, J Biol Chem, 275, 19978, 10.1074/jbc.M908329199
Piedras-Rentería, 2007, Voltage-gated calcium channels, calcium signaling, and channelopathies, 127, 10.1016/S0167-7306(06)41005-X
Strobl, 1990, Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine, Cancer Res, 50, 5399
Krouse, 2015, Repurposing and rescuing of mibefradil, an antihypertensive, for cancer: a case study, Assay Drug Dev Technol, 13, 650, 10.1089/adt.2015.29014.ajkdrrr
Bruce, 2000, Pharmacological evaluation of the role of cytochrome P450 in intracellular calcium signalling in rat pancreatic acinar cells, Br J Pharmacol, 131, 761, 10.1038/sj.bjp.0703631
Merritt, 1990, SK&F 96365, a novel inhibitor of receptor-mediated calcium entry, Biochem J, 271, 515, 10.1042/bj2710515
Zeng, 2013, TRPC channels and their splice variants are essential for promoting human ovarian cancer cell proliferation and tumorigenesis, Curr Cancer Drug Targets, 13, 103, 10.2174/156800913804486629
Sanchez, 2006, Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin, Apoptosis, 11, 89, 10.1007/s10495-005-3275-z
Ramer, 2012, Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1, Faseb J, 26, 1535, 10.1096/fj.11-198184
Trebak, 2002, Comparison of human TRPC3 channels in receptor-activated and store-operated modes. Differential sensitivity to channel blockers suggests fundamental differences in channel composition, J Biol Chem, 277, 21617, 10.1074/jbc.M202549200
Yamashita, 2011, Competitive modulation of Ca2+ release-activated Ca2+ channel gating by STIM1 and 2-aminoethyldiphenyl borate, J Biol Chem, 286, 9429, 10.1074/jbc.M110.189035
Schindl, 2008, 2-aminoethoxydiphenyl borate alters selectivity of Orai3 channels by increasing their pore size, J Biol Chem, 283, 20261, 10.1074/jbc.M803101200
Yamashita, 2014, Divergence of Ca2+ selectivity and equilibrium Ca2+ blockade in a Ca2+ release-activated Ca2+ channel, J General Physiol, 143, 325, 10.1085/jgp.201311108
Ma, 2002, Modification of store-operated channel coupling and inositol trisphosphate receptor function by 2-aminoethoxydiphenyl borate in DT40 lymphocytes, J Biol Chem, 277, 6915, 10.1074/jbc.M107755200
Scrimgeour, 2012, Glu106 in the Orai1 pore contributes to fast Ca2+-dependent inactivation and pH dependence of Ca2+ release-activated Ca2+ (CRAC) current, Biochem J, 441, 743, 10.1042/BJ20110558
Yamashita, 2007, Orai1 mutations alter ion permeation and Ca2+-dependent fast inactivation of CRAC channels: evidence for coupling of permeation and gating, J Gen Physiol, 130, 525, 10.1085/jgp.200709872
Jairaman, 2013, Molecular pharmacology of store-operated CRAC channels, Channels (Austin), 7, 402, 10.4161/chan.25292
Schleifer, 2012, Novel pyrazole compounds for pharmacological discrimination between receptor-operated and store-operated Ca2+ entry pathways, Br J Pharmacol, 167, 1712, 10.1111/j.1476-5381.2012.02126.x
Zitt, 2004, Potent inhibition of Ca2+ release-activated Ca2+ channels and T-lymphocyte activation by the pyrazole derivative BTP2, J Biol Chem, 279, 12427, 10.1074/jbc.M309297200
Ng, 2008, Sustained activation of the tyrosine kinase Syk by antigen in mast cells requires local Ca2+ influx through Ca2+ release-activated Ca2+ channels, J Biol Chem, 283, 31348, 10.1074/jbc.M804942200
Li, 2011, Nanomolar potency and selectivity of a Ca2+ release-activated Ca2+ channel inhibitor against store-operated Ca2+ entry and migration of vascular smooth muscle cells, Br J Pharmacol, 164, 382, 10.1111/j.1476-5381.2011.01368.x
Ramos, 2012, CM3457, a potent and selective oral CRAC channel inhibitor, suppresses T and mast cell function and is efficacious in rat models of arthritis and asthma, J Immunol, 188, 72.3, 10.4049/jimmunol.188.Supp.72.3
Lin, 2013, Generation and characterization of fully human monoclonal antibodies against human Orai1 for autoimmune disease, J Pharmacol Exp Ther, 345, 225, 10.1124/jpet.112.202788